CSIMarket
 
Inspiremd Inc   (NSPR)
Other Ticker:  
 
 
Price: $2.2900 $-0.11 -4.583%
Day's High: $2.4936 Week Perf: -10.36 %
Day's Low: $ 2.29 30 Day Perf: -14.55 %
Volume (M): 33 52 Wk High: $ 3.85
Volume (M$): $ 76 52 Wk Avg: $2.55
Open: $2.45 52 Wk Low: $0.96



 Market Capitalization (Millions $) 56
 Shares Outstanding (Millions) 24
 Employees -
 Revenues (TTM) (Millions $) 6
 Net Income (TTM) (Millions $) -20
 Cash Flow (TTM) (Millions $) 5
 Capital Exp. (TTM) (Millions $) 0

Inspiremd Inc
Inspiremd Inc is a medical technology company that specializes in developing and commercializing neurovascular devices. Their flagship product is the CGuard'' Embolic Prevention System, which is used to prevent strokes caused by the blockage of blood vessels in the brain. This innovative system is designed to capture and remove potential emboli during various endovascular procedures. Inspiremd Inc aims to provide effective and minimally invasive solutions for improving patient outcomes in the field of neurovascular medicine.


   Company Address: 4 Menorat Hamaor St. Tel Aviv 6744832
   Company Phone Number: 776-6804   Stock Exchange / Ticker: NASDAQ NSPR
   NSPR is expected to report next financial results on March 29, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Inspiremd Inc

Inspiremd Inc Achieves Record Revenue Growth and Decreased Losses in Q4 2023

Inspiremd Inc, a medical equipment and supplies company, has seen significant growth in revenue in its latest financial report for the fourth quarter of 2023. The company reported a revenue increase of 58.664% to $1.64 million, which helped to reduce losses to $-0.09 per share, from $-0.60 in the previous year. This growth surpasses the industry average, which only saw a 6.66% increase in revenue during the same period.
Despite a larger net deficit of $-5.405 million compared to $-4.845 million in the previous year, Inspiremd Inc has shown promising growth in inventories and accounts receivable. The company's inventories and supplies have increased to $2.1 million, indicating rising demand, while accounts receivable have also risen to $1.8 million.

Clinical Study

SwitchGuard Neuroprotection System: Advancing Carotid Artery Revascularization Procedures for Enhanced Patient Safety and Outcomes

Published Mon, Feb 12 2024 12:00 PM UTC

Carotid artery disease poses a significant threat to the cardiovascular health of individuals worldwide. With the aim of preventing ischemic strokes and improving patient outcomes, researchers and medical device companies have been actively engaged in developing innovative neuroprotection systems. InspireMD, a leading medical technology company, has recently appointed princi...

Management Changes

InspireMD Appoints Pete Ligotti as EVP and GM of North America Amidst Financial Struggles: A New Hope for the Company's Future

Published Wed, Jan 3 2024 12:00 PM UTC


InspireMD, a leading medical technology company, has recently announced the appointment of Pete Ligotti as their new Executive Vice President and General Manager of North America. Ligotti, a highly experienced medical technology executive, brings over 30 years of general management and commercial leadership expertise to the InspireMD team. This strategic move reflects t...

Contract

InspireMD and Jacobs Institute Join Forces to Revolutionize Stroke Treatment: Breakthrough Early Feasibility Study Holds Promise for Tandem Lesion Patients.

Published Mon, Nov 27 2023 12:00 PM UTC

InspireMD Collaborates with Jacobs Institute to Pave the Way for Advancements in Stroke Treatment
Medical device company InspireMD recently announced a groundbreaking strategic agreement with the renowned Jacobs Institute to conduct a pioneering Early Feasibility Study (EFS). The study aims to evaluate the effectiveness of CGuard Embolic Prevention System (EPS) in treati...






 

Inspiremd Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Inspiremd Inc does not provide revenue guidance.

Earnings Outlook
Inspiremd Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com